Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tetraphase Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TTPH
Nasdaq
8731
https://www.tphase.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tetraphase Pharmaceuticals Inc
Analysts’ Ratings for Sarepta Therapeutics and Peers in April
- Apr 20th, 2018 3:59 pm
Tetraphase Pharmaceuticals’ Cash Flow and Price Performance
- Apr 19th, 2018 5:33 am
Tetraphase Pharmaceuticals to Present Data at the 38th Annual Meeting of the Surgical Infection Society
- Apr 19th, 2018 5:00 am
Exploring Tetraphase Pharmaceuticals’ Financial Performance
- Apr 18th, 2018 1:32 pm
A Look at Tetraphase Pharmaceuticals’ Target Market
- Apr 18th, 2018 1:32 pm
How Analysts View Tetraphase Pharmaceuticals in April 2018
- Apr 18th, 2018 1:32 pm
Blog Exposure - Tetraphase Pharma Announced Data Presentations from IGNITE4 Study at 28th European Congress of Clinical Microbiology and Infectious Diseases
- Apr 16th, 2018 5:20 am
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases
- Apr 12th, 2018 5:00 am
Top High Growth NasdaqCM Stocks This Month
- Apr 11th, 2018 10:02 am
Tetraphase Pharmaceuticals to Present at H.C. Wainwright Annual Global Life Sciences Conference
- Apr 2nd, 2018 5:00 am
New Research: Key Drivers of Growth for First Defiance Financial, Tetraphase Pharmaceuticals, LRAD, LPL Financial, Hubbell, and Castlight Health, inc. — Factors of Influence, Major Initiatives and Sustained Production
- Mar 21st, 2018 6:15 am
Tetraphase Pharmaceuticals to Present at 17th Annual Needham Healthcare Conference
- Mar 20th, 2018 2:01 pm
Is It The Right Time To Buy Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)?
- Mar 7th, 2018 8:35 am
Tetraphase reports 4Q loss
- Mar 6th, 2018 4:09 pm
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones
- Mar 6th, 2018 2:40 pm
Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer
- Mar 1st, 2018 2:01 pm
Priority Review For Tetraphase's Eravacycline A 'Key Positive,' Analyst Says
- Feb 28th, 2018 12:48 pm
Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
- Feb 27th, 2018 6:00 am
Benzinga Pro's Stocks To Watch Today
- Feb 21st, 2018 8:23 am
Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines for Eravacycline in China
- Feb 20th, 2018 2:01 pm
Scroll